These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1233511)

  • 1. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and behavioural studies on the interference between catecholaminergic and serotonergic central systems.
    Allikmets LH; Zharkovsky AM
    Ann Ist Super Sanita; 1978; 14(1):63-70. PubMed ID: 40501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective dopaminergic regulation of stereotyped forms of aggressive and defensive behavior].
    Podol'skiĭ IIa
    Biull Eksp Biol Med; 1977 Apr; 83(4):432-4. PubMed ID: 558022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compounds stimulating central catecholamine receptors].
    Grabowska M
    Postepy Hig Med Dosw; 1973; 27(2):209-39. PubMed ID: 4787947
    [No Abstract]   [Full Text] [Related]  

  • 5. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
    Randrup A; Mogilnicka E
    Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
    Cooper BR; Hester TJ; Maxwell RA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The actions of amphetamine on neurotransmitters: a brief review.
    Moore KE
    Biol Psychiatry; 1977 Jun; 12(3):451-62. PubMed ID: 17437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
    Forsback S; Niemi R; Marjamäki P; Eskola O; Bergman J; Grönroos T; Haaparanta M; Haapalinna A; Rinne J; Solin O
    Synapse; 2004 Feb; 51(2):119-27. PubMed ID: 14618679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-turning induced by electrical stimulation of the caudate nucleus and its antagonism by anti-parkinson drugs.
    Barnett A; Goldstein J
    J Pharmacol Exp Ther; 1975 Aug; 194(2):296-302. PubMed ID: 1171223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
    Leahy JP; Stern WC; Resnick O; Morgane PJ
    Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of stereotyped behaviour induced by apomorphine and amphetamine in the rat.
    Lal S; Sourkes TL
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):171-82. PubMed ID: 4694351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
    Afanas'ev II; Dvorkina ML; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
    Kania BF
    Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.